Breaking News Instant updates and real-time market news.

TEVA

Teva

$8.64

-0.19 (-2.15%)

06:45
06/03/19
06/03
06:45
06/03/19
06:45

Teva upgraded to Outperform from Perform at Oppenheimer

Oppenheimer analyst Esther Rajavelu upgraded Teva Pharmaceutical to Outperform from Perform with a $12 price target.

TEVA Teva
$8.64

-0.19 (-2.15%)

05/30/19
BOFA
05/30/19
DOWNGRADE
BOFA
Underperform
Teva downgraded to Underperform from Buy at BofA/Merrill
05/30/19
BOFA
05/30/19
DOWNGRADE
Target $9
BOFA
Underperform
Teva downgraded to Underperform on litigation risk at BofA/Merrill
As previously reported, BofA/Merrill double downgraded Teva to Underperform from Buy and lowered its price target to $9. Analyst Jason Gerberry said Teva's financial downside to ongoing opioid litigation is difficult to gauge and the highly fragmented nature of the lawsuits makes a global settlement unlikely. Gerberry is also less confident in Teva's generic pipeline catalysts and said 2020+ estimates have downside risk in a flat to negative pricing environment.
05/30/19
WELS
05/30/19
NO CHANGE
WELS
U.S. generic data continues to show challenging environment, says Wells Fargo
Wells Fargo analyst David Maris says that according to April IQVIA data, Teva (TEVA) U.S. generic sales were down 19% in April year over year, while brands sales were down 15%. Additionally, according to IQVIA data, Teva recently ceded its second place U.S. prescription market share place to competitor Eli Lilly (LLY) for its migraine drug, Ajovy, he points out. For Mylan (MYL), Maris says the monthly trends also paint a negative picture, with IQVIA U.S. generic sales in April down 36%. Nonetheless, the analyst believes Teva and Mylan shares seem to be reflecting an "aggressively negative outlook" given the current earnings multiples, and setting aside the worst-case outcomes in the opioid and price fixing cases, these may be at or nearing attractive valuations. However, for now, he remains on the sidelines, and within generics, continues to recommend Outperform-rated Amphastar (AMPH).
05/30/19
05/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying with the valuation back in-line with historical levels and more difficult comps ahead, Verizon's risk/reward is more balanced at current share levels. 2. Canada Goose (GOOS) downgraded to Neutral from Buy at BofA/Merrill with analyst Robert Ohmes saying the Direct-to-Consumer, or DTC, slowdown indicates saturation risk and warrants a lower multiple. 3. ViaSat (VSAT) downgraded to Market Perform from Outperform at Raymond James with analyst Rick Prentiss saying shares are up 55% year-to-date, reflecting good news, and expects an increase in R&D and capex from VS-3 satellite builds and deployments, expanding LatAm operations, and acquiring STCs. 4. Teva (TEVA) double downgraded to Underperform from Buy at BofA/Merrill with analyst Jason Gerberry saying Teva's financial downside to ongoing opioid litigation is difficult to gauge and the highly fragmented nature of the lawsuits makes a global settlement unlikely. 5. Toll Brothers (TOL) downgraded to Market Perform from Outperform at Raymond James with analyst Buck Horne saying he is "concerned" that shares will be range-bound near-term due to reduced estimates, a lack of upcoming catalysts, and lingering West Coast issues. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

PRVB

Provention Bio

$6.09

-0.48 (-7.31%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Provention Bio announces results from Phase 2a PRINCE clinical trial »

Provention Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAN

Anaplan

$44.35

0.34 (0.77%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Upgrade
Anaplan rating change  »

Anaplan upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:08
10/22/19
10/22
07:08
10/22/19
07:08
Earnings
Interpublic Group reports Q3 adjusted EPS 49c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CSIQ

Canadian Solar

$18.51

0.39 (2.15%)

07:07
10/22/19
10/22
07:07
10/22/19
07:07
Hot Stocks
Canadian Solar awarded 30 MWp project in Japan »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

BBY

Best Buy

$71.51

0.89 (1.26%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Hot Stocks
Best Buy announces free next-day shipping for holiday season »

Best Buy announced free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

SGEN

Seattle Genetics

$100.86

13.44 (15.37%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

AER

AerCap

$56.60

0.65 (1.16%)

, BA

Boeing

$331.12

-12.97 (-3.77%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Hot Stocks
AerCap delivers new Boeing 787-9 Dreamliner to Air New Zealand »

AerCap Holdings (AER) has…

AER

AerCap

$56.60

0.65 (1.16%)

BA

Boeing

$331.12

-12.97 (-3.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 08

    Nov

JBLU

JetBlue

$17.54

0.59 (3.48%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Earnings
JetBlue backs FY20 EPS view of $2.50-$3.00, consensus $2.36 »

"We are gaining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

SHW

Sherwin-Williams

$551.04

-9.93 (-1.77%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Earnings
SHW raised FY19 adjusted EPS view to $20.90-$21.30 from $20.40-$21.40 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

RCKT

Rocket Pharmaceuticals

$13.63

0.35 (2.64%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Hot Stocks
Rocket Pharmaceuticals announces FDA clearance of RP-L301 IND »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GOOG

Alphabet

$1,246.23

-0.33 (-0.03%)

, GOOGL

Alphabet Class A

$1,244.23

-0.57 (-0.05%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Recommendations
Alphabet, Alphabet Class A, Facebook, Twitter analyst commentary  »

Ad spending across major…

GOOG

Alphabet

$1,246.23

-0.33 (-0.03%)

GOOGL

Alphabet Class A

$1,244.23

-0.57 (-0.05%)

FB

Facebook

$189.82

3.865 (2.08%)

TWTR

Twitter

$40.09

1.11 (2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

UPS

UPS

$118.56

1.23 (1.05%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Hot Stocks
UPS sees FY19 adjusted free cash flow over $4B »

"UPS delivered solid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

07:05
10/22/19
10/22
07:05
10/22/19
07:05
General news
FX Update: The dollar managed to lift against most currencies »

FX Update: The dollar…

AVRO

Avrobio

$14.18

0.38 (2.75%)

07:04
10/22/19
10/22
07:04
10/22/19
07:04
Hot Stocks
Avrobio appoints Holly May as Chief Commercial Officer »

Avrobio announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABG

Asbury Automotive

$106.00

2.63 (2.54%)

07:04
10/22/19
10/22
07:04
10/22/19
07:04
Hot Stocks
Asbury Automotive reports Q3 same store results »

Q3 same store: Total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 05

    Dec

JBLU

JetBlue

$17.54

0.59 (3.48%)

07:04
10/22/19
10/22
07:04
10/22/19
07:04
Hot Stocks
JetBlue sees Q4 capacity up 4.5%-6.5%, FY19 up 6%-7% »

For Q4, capacity is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

UPS

UPS

$118.56

1.23 (1.05%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
Breaking Earnings news story on UPS »

UPS reaffirms FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

JBLU

JetBlue

$17.54

0.59 (3.48%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
JetBlue reports Q3 adjusted EPS 59c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

UTX

United Technologies

$138.24

1.39 (1.02%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
United Technologies raises FY19 adj. EPS view to $8.05-8.15 from $7.90-$8.05 »

Consensus $8.03. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ABG

Asbury Automotive

$106.00

2.63 (2.54%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
Asbury Automotive reports Q3 EPS $2.33, consensus $2.32 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 05

    Dec

BIIB

Biogen

$223.57

3.52 (1.60%)

, ALKS

Alkermes

$18.41

0.24 (1.32%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Hot Stocks
Biogen preparing to launch Vumerity for multiple sclerosis »

Biogen (BIIB) said in its…

BIIB

Biogen

$223.57

3.52 (1.60%)

ALKS

Alkermes

$18.41

0.24 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 06

    Nov

NVS

Novartis

$86.55

-0.305 (-0.35%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Hot Stocks
Breaking Hot Stocks news story on Novartis »

Novartis reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Dec

SHW

Sherwin-Williams

$551.04

-9.93 (-1.77%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Earnings
Sherwin-Williams reports Q3 EPS ex-items $6.65, consensus $6.48 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

UPS

UPS

$118.56

1.23 (1.05%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Earnings
UPS reports Q3 adjusted EPS $2.07, consensus $2.06 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

NVS

Novartis

$86.55

-0.305 (-0.35%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Earnings
Novartis raises FY19 net sales view to up high single digits »

Previous guidance was up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.